EHC
Encompass Health Corp
NYSE · Healthcare · Medical - Care Facilities · US
$139.44
+3.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.3B | 5.9B | 5.4B | 4.8B | 4.3B |
| Cost of Revenue | 3.9B | 3.4B | 3.1B | 2.8B | 2.6B |
| Gross Profit | 2.4B | 2.6B | 2.2B | 2.0B | 1.8B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 293.5M | 295.2M | 266.5M | 258.0M | 209.0M |
| General & Admin Expense | 293.5M | 295.2M | 266.5M | 258.0M | 209.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 987.2M | 1.2B | 1.1B | 993.0M | 914.0M |
| Total Operating Expenses | 1.3B | 1.5B | 1.4B | 1.3B | 1.1B |
| Cost and Expenses | 5.2B | 4.9B | 4.5B | 4.1B | 3.7B |
| Operating Income (EBIT) | 1.2B | 1.1B | 864.5M | 731.8M | 630.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 127.0M | 123.2M | 137.4M | 143.5M | 175.7M |
| Net Interest Income | (127.0M) | (123.2M) | (137.4M) | (143.5M) | (175.7M) |
| Other Non-Op Income/Expense | (95.6M) | (100.1M) | (114.9M) | (124.6M) | (179.4M) |
| Non-Operating Income (excl Interest) | (31.4M) | (23.1M) | (22.5M) | (18.9M) | 3.7M |
| EBT (Pre-Tax Income) | 1.1B | 953.0M | 749.6M | 607.2M | 450.8M |
| Income Tax Expense | 218.8M | 192.9M | 150.2M | 132.2M | 100.1M |
| Bottom Line | |||||
| Net Income | 644.4M | 566.2M | 455.7M | 352.0M | 271.0M |
| Earnings from Cont. Ops | 847.0M | 760.1M | 599.4M | 475.0M | 350.7M |
| Earnings from Discont. Ops | 15.3M | (1.0M) | (2.8M) | (12.0M) | 15.2M |
| Bottom Line Net Income | 644.4M | 566.2M | 455.7M | 352.0M | 271.0M |
| Per Share | |||||
| Basic EPS | $6.48 | $5.62 | $4.53 | $3.54 | $2.72 |
| Diluted EPS | $6.40 | $5.54 | $4.46 | $3.47 | $2.70 |
| Revenue Per Share | $64.48 | $59.06 | $53.79 | $48.25 | $43.84 |
| Shares | |||||
| Basic Shares Outstanding | 98.3M | 100.5M | 99.9M | 99.5M | 99.2M |
| Diluted Shares Outstanding | 99.7M | 102.2M | 102.2M | 101.3M | 100.4M |
| Profitability Metrics | |||||
| EBITDA | 1.6B | 1.4B | 1.2B | 1.0B | 870.1M |
| D&A | 359.8M | 327.9M | 299.6M | 273.9M | 243.6M |
| EBIT | 1.2B | 1.1B | 887.0M | 750.7M | 626.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026